The Desmoid Tumor Research Foundation

July 2018

Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: A preliminary study

Author Information

Gondim Teixeira PA(1), Chanson A(1), Verhaeghe J-L(2), Lecocq S(1), Louis M(1), Hossu G(3,4), Blum A(1)

(1)Guilloz Dept of Radiology, CHRU de Nancy, 54000 Nancy, France. (2)Dept of Surgery, Institut de Cancerologie de Lorraine, 6, avenue de Bourgogne, 54519 Vandoeuvre-les-Nancy, France. (3)IADI U947, universite de Lorraine, 54500 Nancy, France. (4)Inserm, CIC-IT 1433, 54500 Nancy, France.

Publication

Diag Inter Imag

Summary

To evaluate the impact of hormonal therapy on MRI characteristics of desmoid-type fibromatosis on T1-weighted, T2-weighted fat-saturated and post-contrast sequences. There was a significant reduction in enhancement among treated patients with stable/regressing disease (P = 0.049). The mean variation in enhancement grade was 1.3 ± 1.2 in these patients. All successfully treated patients presented a reduction in enhancement. Lesions with marked low enhancement or very low signal on T2-weighted images were rare in progressing lesions (0% and 13%). Hormonal therapy has an impact on desmoid-type fibromatosis signal characteristics reducing lesion enhancement.

View Abstract